Navigation Links
Laureate Pharma Welcomes Three New Members to Business Development Team
Date:11/2/2009

PRINCETON, N.J., Nov. 2 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company specializing in the development and manufacture of monoclonal antibody products, fusion proteins and other recombinant protein products, today announced the addition of three new members to its Business Development team. "We're delighted to have three new team members with such extensive experience and expertise in outsourcing services and customer support joining our team," said Dan Leone, Vice President, Business Development. "We will have two team members covering eastern US/Canada and one covering western US/Canada."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

Andrew Arrage joins Laureate as Director, Business Development - East. Andrew has over 15 years of experience and a proven track record in the biopharmaceutical services industry, delivering services to clients in the biotech and pharmaceutical industries.

Patricia Caplan joins Laureate as Director, Business Development - East. Patricia brings more than 20 years of experience working with clients to develop their therapeutic protein products and move them from the bench into the clinic and on to commercialization.

Bruce Frazier joins Laureate as Manager, Business Development - West. Bruce, who most recently worked in business development at a biopharmaceutical services company, has applied his experience as a quality control skilled scientist to become an accomplished business development professional dedicated to serving clients requiring biopharmaceutical testing and manufacturing services.

"Andrew, Patricia and Bruce add great depth and valuable experience to our business development team," said Robert J. Broeze, Ph.D., President and CEO of Laureate. "With their strong customer service and project management skills they will play a key role in expanding Laureate's portfolio of client projects and providing critical support to our customer base."

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, NJ. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. For more information, contact Dan Leone, Vice President, Business Development at 609-919-3300, or info@laureatepharma.com or visit www.laureatepharma.com.

Available Topic Expert: For information on the listed expert, click appropriate link.

Robert Broeze

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=84360

SOURCE Laureate Pharma, Inc.


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Reuters Predicts Nobel Laureates
2. Laureate Pharma Elects New Board Member
3. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
4. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
5. US Oncology Named 2009 Laureate by IDG Computerworld Honors Program
6. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
7. Laureate Pharma Honored as Emerging Life Sciences Company of the Year
8. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
9. Laureate Announces Manufacturing Agreement with Tolerx
10. Laureate Pharma to Add More Manufacturing Capacity
11. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
Breaking Biology News(10 mins):